Yoshiaki Abe

1.8k total citations
74 papers, 1.1k citations indexed

About

Yoshiaki Abe is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yoshiaki Abe has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 18 papers in Molecular Biology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Yoshiaki Abe's work include Multiple Myeloma Research and Treatments (18 papers), Lymphoma Diagnosis and Treatment (16 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). Yoshiaki Abe is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Lymphoma Diagnosis and Treatment (16 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). Yoshiaki Abe collaborates with scholars based in Japan, United States and France. Yoshiaki Abe's co-authors include Takashi Horie, Shu Hashimoto, Kosei Matsue, Kentaro Narita, Masami Takeuchi, Hiroki Kobayashi, Akihiro Kitadate, Daisuke Miura, Kengo Takeuchi and Toshihiro O’uchi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Yoshiaki Abe

68 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiaki Abe Japan 15 318 230 202 193 189 74 1.1k
Borko Jovanovic United States 19 179 0.6× 33 0.1× 215 1.1× 229 1.2× 356 1.9× 34 1.5k
Dieter Mitteregger Austria 14 277 0.9× 58 0.3× 117 0.6× 125 0.6× 157 0.8× 30 1.2k
Xueyuan Heng China 15 466 1.5× 284 1.2× 99 0.5× 132 0.7× 31 0.2× 30 1.1k
Abdelhamid Liacini United States 12 455 1.4× 74 0.3× 248 1.2× 216 1.1× 73 0.4× 48 1.4k
Emiliano Antiga Italy 24 189 0.6× 87 0.4× 78 0.4× 533 2.8× 806 4.3× 88 2.1k
Kazunori Hata Japan 19 239 0.8× 51 0.2× 311 1.5× 487 2.5× 97 0.5× 41 1.3k
Ken Takeuchi Japan 23 398 1.3× 212 0.9× 224 1.1× 674 3.5× 75 0.4× 62 2.2k
Isabelle Lamarche France 18 244 0.8× 176 0.8× 84 0.4× 41 0.2× 20 0.1× 40 1.0k
Blake M. Warner United States 18 313 1.0× 31 0.1× 179 0.9× 153 0.8× 64 0.3× 61 1.0k
Maral Mokhtari Iran 14 109 0.3× 45 0.2× 106 0.5× 61 0.3× 141 0.7× 109 650

Countries citing papers authored by Yoshiaki Abe

Since Specialization
Citations

This map shows the geographic impact of Yoshiaki Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Abe more than expected).

Fields of papers citing papers by Yoshiaki Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiaki Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Abe. The network helps show where Yoshiaki Abe may publish in the future.

Co-authorship network of co-authors of Yoshiaki Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiaki Abe. A scholar is included among the top collaborators of Yoshiaki Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiaki Abe. Yoshiaki Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suehara, Yasuhito, Yoshiaki Abe, Ryota Matsuoka, et al.. (2024). Genetic profiles and clinical features in subcutaneous panniculitis‐like T‐cell lymphomas. Cancer Science. 115(11). 3788–3794. 1 indexed citations
2.
Abe, Yoshiaki. (2023). Follicular lymphoma microenvironment: insights provided by single-cell analysis. Journal of Clinical and Experimental Hematopathology. 63(3). 143–151. 5 indexed citations
3.
Miura, Daisuke, Kentaro Narita, Rikako Tabata, et al.. (2019). Clinical and Prognostic Impact of (11;14)(q13;q32) Translocation on Patients with Multiple Myeloma. Blood. 134(Supplement_1). 5507–5507. 1 indexed citations
4.
Abe, Yoshiaki, Kentaro Narita, Hiroki Kobayashi, et al.. (2019). 18F-FDG PET/CT-Guided Diagnosis and Evaluation of Treatment Response to Cyclosporine A in Maldistributed Subcutaneous Panniculitis-like T-Cell Lymphoma Without Typical Skin Rash. Clinical Nuclear Medicine. 45(2). e69–e71. 3 indexed citations
5.
Kobayashi, Hiroki, Toshiki Terao, Yoshiaki Abe, et al.. (2019). Evaluation of the safety and efficacy of daratumumab outside of clinical trials. International Journal of Hematology. 109(6). 665–672. 11 indexed citations
6.
7.
Abe, Yoshiaki, Yoshiaki Usui, Kentaro Narita, Masami Takeuchi, & Kosei Matsue. (2018). Concomitant subcutaneous intravascular lymphoma lesions in a patient with cardiac diffuse large B-cell lymphoma: is intravascular lymphoma a distinct clinical entity?. International Journal of Hematology. 108(6). 637–639. 4 indexed citations
8.
Abe, Yoshiaki, Kentaro Narita, Hiroki Kobayashi, et al.. (2018). Clinical value of abnormal findings on brain magnetic resonance imaging in patients with intravascular large B-cell lymphoma. Annals of Hematology. 97(12). 2345–2352. 24 indexed citations
9.
Abe, Yoshiaki, Kentaro Narita, Hiroki Kobayashi, et al.. (2017). Normalization of the Serum Free Light Chain Ratio in Patients with Intact Immunoglobulin Multiple Myeloma Who Achieve Less Than Complete Response. Blood. 130. 5380–5380. 1 indexed citations
10.
Suehara, Yasuhito, Mamiko Sakata‐Yanagimoto, Keiichiro Hattori, et al.. (2017). Liquid Biopsy for the Identification of Intravascular Large B-Cell Lymphoma. Blood. 130. 378–378. 6 indexed citations
11.
12.
Narita, Kentaro, Hiroki Kobayashi, Yoshiaki Abe, Masami Takeuchi, & Kosei Matsue. (2017). Evaluation of Risk Factors and Survival Effect of Delayed Excretion of High-Dose Methotrexate in Patients with Leukemia and Lymphoma. Blood. 130. 4132–4132. 2 indexed citations
13.
14.
Abe, Yoshiaki, Shu Hashimoto, & Takashi Horie. (1999). CURCUMIN INHIBITION OF INFLAMMATORY CYTOKINE PRODUCTION BY HUMAN PERIPHERAL BLOOD MONOCYTES AND ALVEOLAR MACROPHAGES. Pharmacological Research. 39(1). 41–47. 363 indexed citations
15.
Yoshimura, Hirokuni, Jun Shinada, T Koh, Yoshiaki Abe, & Akira Ishihara. (1993). Chest Wall Invasion in Carcinoma of the Lung: Therapeutic and Prognostic Implication. 23(6). 446–451. 2 indexed citations
16.
Nakahara, Takako, et al.. (1990). Increased vascular permeability, erythema, and leukocyte emigration induced in rabbit skin by streptococcal erythrogenic toxin type A. FEMS Microbiology Letters. 68(1-2). 159–162. 4 indexed citations
17.
Abe, Yoshiaki, Shoko Nakano, Takako Nakahara, et al.. (1990). Detection of Serum Antibody by the Antimitogen Assay against Streptococcal Erythrogenic Toxins. Age Distribution in Children and the Relation to Kawasaki Disease. Pediatric Research. 27(1). 11–15. 22 indexed citations
18.
Abe, Yoshiaki, Tomohiko Matsuzawa, T. Fujiwara, et al.. (1985). Clinical Studies with 18F-5-Fluoro-Deoxyuridine in Lung Cancer. 1985. 191–195. 1 indexed citations
19.
Abe, Yoshiaki, et al.. (1976). Glass Particles in Parenteral Solution Arising from Ampule-cutting Process. Japanese Journal of Hospital Pharmacy. 2(2). 111–116. 1 indexed citations
20.
Abe, Yoshiaki. (1971). Lymphocyte stimulation with streptolysin O preparations. I. Purification of streptolysin O and the existence of two stimulants for rabbit lymphocytes cultured in vitro.. PubMed. 41(5). 431–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Borko Jovanovic Breakdown of academic impact, for papers by Dieter Mitteregger Breakdown of academic impact, for papers by Xueyuan Heng Breakdown of academic impact, for papers by Abdelhamid Liacini Breakdown of academic impact, for papers by Emiliano Antiga Breakdown of academic impact, for papers by Kazunori Hata Breakdown of academic impact, for papers by Ken Takeuchi Breakdown of academic impact, for papers by Isabelle Lamarche Breakdown of academic impact, for papers by Blake M. Warner Breakdown of academic impact, for papers by Maral Mokhtari
Rankless by CCL
2026